Schneider Downs Wealth Management Advisors LP lowered its holdings in Danaher Co. (NYSE:DHR) by 12.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 865 shares of the conglomerate’s stock after selling 127 shares during the quarter. Schneider Downs Wealth Management Advisors LP’s holdings in Danaher were worth $263,000 at the end of the most recent quarter.
A number of other hedge funds have also made changes to their positions in DHR. Symmetry Investments LP acquired a new position in shares of Danaher during the second quarter valued at about $4,428,000. Islet Management LP purchased a new position in Danaher during the 2nd quarter worth $13,418,000. Public Employees Retirement System of Ohio boosted its holdings in Danaher by 0.3% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 415,854 shares of the conglomerate’s stock worth $111,599,000 after acquiring an additional 1,112 shares during the last quarter. Wilbanks Smith & Thomas Asset Management LLC grew its stake in shares of Danaher by 3.3% in the 2nd quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 56,026 shares of the conglomerate’s stock worth $15,035,000 after acquiring an additional 1,806 shares in the last quarter. Finally, Advisor Group Holdings Inc. raised its holdings in shares of Danaher by 3.7% in the second quarter. Advisor Group Holdings Inc. now owns 138,714 shares of the conglomerate’s stock valued at $37,266,000 after purchasing an additional 4,937 shares during the last quarter. Institutional investors and hedge funds own 88.49% of the company’s stock.
Shares of Danaher stock opened at $315.48 on Thursday. The stock has a market capitalization of $225.43 billion, a P/E ratio of 39.98, a P/E/G ratio of 2.35 and a beta of 0.70. Danaher Co. has a 52-week low of $211.22 and a 52-week high of $333.96. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.11 and a current ratio of 1.48. The stock’s 50-day simple moving average is $308.25 and its 200 day simple moving average is $292.45.
The firm also recently announced a quarterly dividend, which was paid on Friday, October 29th. Shareholders of record on Thursday, September 30th were issued a dividend of $0.21 per share. The ex-dividend date of this dividend was Wednesday, September 29th. This represents a $0.84 dividend on an annualized basis and a yield of 0.27%. Danaher’s payout ratio is 10.65%.
Several equities research analysts have commented on the stock. KeyCorp increased their price objective on shares of Danaher from $315.00 to $345.00 and gave the company an “overweight” rating in a research note on Friday, October 22nd. Royal Bank of Canada increased their price target on Danaher from $332.00 to $334.00 and gave the company a “sector perform” rating in a research report on Friday, October 22nd. Barclays boosted their price objective on Danaher from $335.00 to $355.00 and gave the stock an “overweight” rating in a research report on Friday, October 22nd. Bank of America raised their target price on Danaher from $340.00 to $360.00 and gave the company a “buy” rating in a research report on Friday, September 10th. Finally, Credit Suisse Group boosted their price target on shares of Danaher from $306.00 to $370.00 and gave the stock an “outperform” rating in a report on Friday, September 10th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $334.36.
In other news, EVP Joakim Weidemanis sold 5,000 shares of the company’s stock in a transaction dated Wednesday, November 10th. The stock was sold at an average price of $297.55, for a total transaction of $1,487,750.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Linda P. Hefner sold 2,185 shares of the business’s stock in a transaction that occurred on Thursday, November 11th. The shares were sold at an average price of $303.72, for a total transaction of $663,628.20. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 694,908 shares of company stock worth $214,929,432. Company insiders own 11.40% of the company’s stock.
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines.
Recommended Story: What is a Buy-Side Analyst?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.